key: cord-0881595-bdl2rioi authors: Acquavia, Maria A.; Foti, Luca; Pascale, Raffaella; Nicolò, Antonia; Brancaleone, Vincenzo; Cataldi, Tommaso R.I.; Martelli, Giuseppe; Scrano, Laura; Bianco, Giuliana title: Detection and quantification of Covid-19 antiviral drugs in biological fluids and tissues date: 2020-11-05 journal: Talanta DOI: 10.1016/j.talanta.2020.121862 sha: 054da20d6d657c00f63a3272beecd87f965ecc72 doc_id: 881595 cord_uid: bdl2rioi Since coronavirus disease 2019 (COVID-19) started as a fast-spreading pandemic, causing a huge number of deaths worldwide, several therapeutic options have been tested to counteract or reduce the clinical symptoms of patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, no specific drugs for COVID-19 but many antiviral agents have been authorised by several national agencies. Most of them are under investigation in both preclinical and clinical trials; however, pharmacokinetic and metabolism studies are needed to identify the most suitable dose to achieve the desired effect on SARS-CoV-2. Therefore, the efforts of the scientific community have focused on the screening of therapies able to counteract the most severe effects of the infection, as well as on the search of sensitive and selective analytical methods for drug detection in biological matrices, both fluids and tissues. In the last decade, many analytical methods have been proposed for the detection and quantification of antiviral compounds currently being tested for COVID-19 treatment. In this review, a critical discussion on the overall analytical procedure is provided, i.e (a) sample pre-treatment and extraction methods such as protein precipitation (PP), solid-phase extraction (SPE), liquid–liquid extraction (LLE), ultrasound-assisted extraction (UAE) and QuEChERS (quick, easy, cheap, effective, rugged and safe), (b) detection and quantification methods such as potentiometry, spectrofluorimetry and mass spectrometry (MS) as well as (c) methods including a preliminary separation step, such as high performance liquid chromatography (HPLC) and capillary electrophoresis (CE) coupled to UV-Vis or MS detection. Further current trends, advantages and disadvantages and prospects of these methods have been discussed, to help the analytical advances in reducing the harm caused by the SARS-CoV-2 virus. In spite of quick and easy extraction, traditional protein precipitation is characterised by low selectivity, 244 because of the analytes co-precipitation [56, 71] . Moreover, it fails to sufficiently remove endogenous 245 compounds such as lipids, phospholipids, fatty acids whose co-elution with the compounds of interest 246 affects the ESI droplet desolvation process [72] . Therefore, PP is used as a pre-treatment of plasma CE is based on the separation of charged analytes through a small capillary under the influence 379 of an electric field; thus, it represent a good alternative to conduct faster analysis with higher efficiency 380 than LC [113] . However, the main disadvantage of CE is its low concentration sensitivity. In this The fragmentation pattern of COVID-19 tested antiviral drugs is well known for most of them. For each analyte and the IS, the matrix factor (MF) should be calculated for 6 lots of blank matrix, by the ratio of the peak area in the presence of matrix (measured by analysing blank matrix spiked after extraction with analyte), to the peak area in absence of matrix (pure solution of the analyte). Fastest and simplest extraction technique. It can be used also as sample pre-treatment before applying other extraction techniques. Low selectivity; it could induce analytes co-precipitation. It does not sufficiently remove endogenous compounds such as lipids, phospholipids and fatty acids. Plasma, cell lysates, cerebrospinal fluid, chicken tissue, poultry muscle. It combines extraction, clean-up and concentration procedures in a single step. It ensures analytes extraction with high selectivity. Slightly tedious and time-consuming extraction technique. In some cases, it could result in less intense chromatographic peaks if compared to liquid-liquid extraction. Plasma, urine, feces, hairs, mice vaginal tissues, liver tissues, poultry muscles, peripheral blood mononuclear cells, and human placental choriocarcinoma trophobplast cells. Faster and easier than SPE. It desalts samples very well, lessening the problem of source fouling in mass spectrometry analyses. Time-consuming technique and a rather hazardous one, due to the use of large amounts of toxic organic solvents. It is less selective than solid-phase extraction; moreover, the possibility of emulsion formation prevents automation of this technique. Urine, chicken tissue, dried sample spots. Ultrasound increases the rate of mass transfer of analytes from matrix in the solvent compared to the classic liquidliquid extraction. Technique not widespread for the extraction from biological matrices. Plasma, chicken muscle. More suitable for the extraction of drugs from biological tissues compared to liquid-liquid extraction or solid-phase extraction. It is a quick, easy, cheap, effective, rugged and safe method, ensuring an high selectivity of the extraction. The QuEChERS method yields final extracts less concentrated compared to the traditional extraction techniques. Table 3 . Analytical methods employed in the last ten years for the detection of antivirals currently tested for COVID-19 treatment, with their main 1248 advantages and drawbacks. Fast and economical possibility to monitor the drug of interest thanks to ion-selective electrodes, whose the electric potential created over membrane depends on its the activity and allows its quantification. Still limited since many common ions occurring in biofluids and tissues could interfere with the measurement of the target analyte. Easy, less expensive and less time consuming methods; they offer better sensitivity compared to potentiometric methods. Sometimes require derivatization steps before the detection to form fluorescent adducts, since not all the antivirals are characterized by native fluorescence. Endogenous compounds could interfere with the results of the analysis. Short analysis times and low ion suppression. Quantification remains a major challenge due to problems associated with analyte recovery from the tissue and ionization matrix effects. High performance liquid chromatography coupled to UV-Vis (HPLC-UV) Better sensitivity compared to CE-UV. Possibility to carry out multiresidue analysis. Sensitivity and selectivity are rather limited because LC-UV requires a huge volume of sample and complex sample preparation to detect drugs at a low concentration. High performance liquid chromatography coupled to spectrofluorometric detection (LC-FL) More sensitive and selective than LC-UV, since fluorescence is a characteristic of well-defined compounds. Since not all the antivirals are characterized by native fluorescence, sometimes are required derivatization steps before the analysis. Faster analysis with higher efficiency than LC-UV, thanks to the drugs separation through a small capillary under the influence of an electric field. Low concentration sensitivity J o u r n a l P r e -p r o o f New insights on the antiviral effects of 627 chloroquine against coronavirus: what to expect for COVID-19? Health Organization declares global emergency: A review of the 2019 novel coronavirus 631 (COVID-19) Evaluation of Ebola 634 Virus Inhibitors for Drug Repurposing Antimalarial agents: chloroquine, hydroxychloroquine, and 637 quinacrine Baricitinib : First Global Approval Development and validation of a dried blood spot assay for the quantification of ribavirin using 749 liquid chromatography coupled to mass spectrometry Parallel ultra high pressure liquid chromatography-752 mass spectrometry for the quantification of HIV protease inhibitors using dried spot sample 753 collection format /MS analysis of oseltamivir and oseltamivircarboxylate-a validated assay for the 758 clinic Development 760 and validation of a LC-MS/MS method for the quantification of tenofovir and emtricitabine in 761 seminal plasma Stability indicating determination of darunavir with hplc in blood 764 plasma samples A New Validated Potentiometric Method 767 ultrafast isotope dilution MALDI-triple quadrupole tandem mass spectrometry Quantitative mass spectrometry imaging of emtricitabine in cervical tissue model using infrared 999 matrix-assisted laser desorption electrospray ionization Using Potentiometric Free Drug Sensors to Determine the Free Concentration of Ionizable Drugs 1003 in Colloidal Systems Sulfadiazine-potentiometric 1006 sensors for flow and batch determinations of sulfadiazine in drugs and biological fluids Potentiometric sensors for trace-level analysis, TrAC -Trends Anal Spectrophotometric and 1011 spectrofluorometric methods for the determination of non-steroidal anti-inflammatory drugs: A 1012 review Capillary 1014 electrophoresis as a versatile tool for the bioanalysis of drugs -A review Development and 1028 validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin 1029 in blood and erythrocytes of HCV+ patients Validated RP-HPLC method 1032 development for estimation of Tenofovir Disoproxil Fumarate from plasma Age-related changes in plasma concentrations of the HIV protease 1036 inhibitor lopinavir Impurity profiling of drug candidates: 1039 Analytical strategies using reversed-phase and mixed-mode high-performance liquid 1040 chromatography methods Separation methods for acyclovir and related antiviral 1043 compounds Division, Effect of mobile phase pH on the separation of drugs 1046 using high-performance liquid chromatography A review on liquid chromatography-tandem mass 1049 spectrometry methods for rapid quantification of oncology drugs Use of micellar liquid 1052 chromatography to analyze darunavir , ritonavir , emtricitabine , and tenofovir in plasma Direct Serum Injection with Micellar Liquid Development of a sensitive LC assay with fluorescence detection for the determination of 1059 zearalenone in rat serum Polybrominated 1062 diphenyl ethers (PBDEs) in Mediterranean mussels Apulia coastal sites evaluated by GC-HRMS Determination of soyasaponins in Fagioli di Sarconi beans 1067 (Phaseolus vulgaris L.) by LC-ESI-FTICR-MS and evaluation of their hypoglycemic activity Small molecule analysis by MALDI mass spectrometry Validation of a liquid chromatography coupled with tandem mass 1073 spectrometry method for the determination of drugs in wastewater using a three-phase solvent 1074 system Utility of imaging mass spectrometry (IMS) by matrix-assisted 1077 laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs 1078 and metabolites in biological tissues Think 1081 Negative: Finding the Best Electrospray Ionization/MS Mode for Your Analyte Quantification in MALDI-MS imaging: what can 1121 we learn from MALDI-selected reaction monitoring and what can we expect for imaging? A new combination MALDI matrix for small molecule analysis: Application to imaging 1125 mass spectrometry for drugs and metabolites IR-MALDESI mass spectrometry imaging of 1128 biological tissue sections using ice as a matrix Validation of liquid chromatography-tandem 1132 mass spectrometric method for simultaneous determination of lopinavir and ritonavir in human 1133 plasma, and its application in a bioequivalescence study in Thai volunteers Quantitation of 1136 ribavirin in human plasma and red blood cells using LC -MS / MS Effect 1139 of pH and mobile phase additives on the chromatographic behaviour of an amide-embedded 1140 stationary phase: Cyanocobalamin and its diaminemonochloro-platinum(II) conjugate as a case 1141 study Comprehensive investigation of the 1143 influence of acidic, basic, and organic mobile phase compositions on bioanalytical assay 1144 sensitivity in positive ESI mode LC/MS/MS Matrix effect in bio-analysis of illicit 1147 drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC-1182 Validation of simultaneous quantitative method of HIV protease 1185 inhibitors atazanavir, darunavir and ritonavir in human plasma by UPLC-MS/MS A novel LC-MS/MS method for 1188 simultaneous quantification of tenofovir and lamivudine in human plasma and its application to 1189 a pharmacokinetic study LC-MS/MS quantitation of ribavirin in serum and 1192 identification of endogenous isobaric interferences MS Method for the Determination of Tenofovir in Monkey Plasma Simple, rapid and validated LC determination of lopinavir in 1197 rat plasma and its application in pharmacokinetic studies Development of an LC-MS method for 1200 measuring TNF in human vaginal tissue Simultaneous 1203 determination of ritonavir and lopinavir in human plasma after protein precipitation and Simultaneous 1206 quantification of emtricitabine and tenofovir nucleotides in peripheral blood mononuclear cells 1207 using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry Higher selectivity and sensibility compared to LC-UV methods. Shorter analysis time. Possibility to carry out multiresidue analysis.Susceptibility to matrix effects, due to the outcome of co-eluting interfering compounds on the analyte ionization.Ultra-high performance liquid chromatography coupled to mass spectrometry (UHPLC-MS) Improved chromatographic efficiency compared to high performance liquid chromatography (HPLC) columns. Less susceptible to matrix effect.Due to the smaller particles in the column, a more tedious pre-treatment of the sample in order to avoid its clogging is needed.  Chemical formula: C36H47N5O4  Molecular weight: 613.8 g/mol  logP value: 2.9  pKa values: 3.8; 6.2